Finasteride Treatment of Hair Loss in Women

  title={Finasteride Treatment of Hair Loss in Women},
  author={Stephen Marc Stout and Janice L. Stumpf},
  journal={Annals of Pharmacotherapy},
  pages={1090 - 1097}
Objective: To review available evidence on the safety and efficacy of finasteride in the treatment of alopecia in women. Data Sources: A literature search was conducted through PubMed (1948–March 2010) and MEDLINE (1950–March 2010) using the search terms finasteride and alopecia. References cited in relevant publications were reviewed. Study Selection and Data Extraction: All data sources identified were reviewed for inclusion. Reports of finasteride treatment of female alopecia were included… 

Tables from this paper

Guidelines on the use of finasteride in androgenetic alopecia

Current evidence on the safety of finasteride indicates that it is safe but there is growing concern about its sexual side effects.

Prospective Cohort Study on the Effects and Tolerability of Flutamide in Patients with Female Pattern Hair Loss

Flutamide is a satisfactory therapeutic regimen for treatment of FPHL in the long run and the use of very low doses (62.5 mg/day) of flutamide are associated with complete hepatic tolerability and high adherence.

The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.

Both age categories showed a statistically significant increase in hair thickness from baseline over the 3-year period for finasteride and dutasteride, which effectively increased hair thickness and arrested further deterioration in women with androgenetic alopecia.

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

This review aims to provide novel therapeutic options including topical finasteride and dutasteride, a new generation 5-ARI, for the treatment of FPHL.


It is observed that Serenoa repens could lead to an improvement of androgenetic alopecia, while finasteride confirmed its efficacy.

Comparitive Effectiveness and Finasteride Vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study

It is observed that Serenoa repens could lead to an improvement of androgenetic alopecia, while finasteride confirmed its efficacy.

Treatment options for alopecia: an update, looking to the future

Current treatment options for the most common forms of hair loss are summarized, and the literature on treatment options to emerge over the 3 years since the release of the first edition of this article is updated.

Efficacy of Finasteride Treatment Versus Low-Level Laser in Frontal Male and Female Pattern Hair Loss

Both finasteride treatment (FST) and low level laser (LLL) were effective and nearly equivalent in improving hair regrowth in frontal male and female pattern hair loss as manifested by the increased 7-PAS and HCM at the end of the treatment program.

The efficacy and use of finasteride in women: a systematic review

The purpose of this study is to better define the efficacy and use of finasteride in women and identify research gaps that require further investigation.

Androgenetic Alopecia: An Update of Treatment Options

The current treatment alternatives for androgenetic alopecia including their efficacy, safety profile, and quality of evidence are discussed.



Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women

Oral finasteride in a dosage of 2.5 mg/day or more may be effective for the treatment of pattern hair loss in postmenopausal women in the absence of clinical or laboratory signs of hyperandrogenism.

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.

In postmenopausal women with AGA, finasteride 1 mg/day taken for 12 months did not not increase hair growth or slow the progression of hair thinning.

Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.

Topical minoxidil was significantly more effective than placebo in the treatment of female androgenetic alopecia and the number of nonvellus hairs regrown was increased.

Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid.

Topical solution of estradiolbenzoate, prednisolon and salicylic acid is an efficacious and safety treatment of androgenetic alopecia in females.

Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone

Nine of the 12 patients benefited from the treatment, their symptoms decreased significantly and they felt better psychologically than before the administration of finasteride, supporting the hypothesis of an excessive activity of 5α-reductase enzyme in peripheral tissue in patients with acne or alopecia.

Effective treatment of female androgenic alopecia with dutasteride.

Dihydrotestosterone is the main molecule responsible for androgenic alopecia. Finasteride, which reduces transformation of testosterone into dihydrotestosterone and decreases dihydrotestosterone

Hair loss in women with hyperandrogenism: four cases responding to finasteride.

The finding that finasteride treatment improves pattern hair loss in women with hyperandrogenism but does not affect those postmenopausal women with female patternhair loss without hyperandrogensism supports the concept that not all types of female hair loss have the same pathophysiology.